Georgetown Law Journal / Trans-Pacific Partnership / Alabama Law Review / Technology Law Review / Kentucky Law Review / Michigan Telecommunications / Texas Law Review / /
Country
United States / /
Currency
USD / /
Event
Patent Issuance / FDA Phase / /
Facility
University of Baltimore Intellectual Property Law Journal / /
IndustryTerm
biotechnology / pharmaceutical industry / drug product / qualified infectious disease product / pharmaceutical test data / generic product / chemical variants / pharmaceutical / generic manufacturer / federal law / potential generic manufacturer / pharmaceuticals / healthcare industry / agricultural chemicals / pharmaceutical innovation / chemical entities / brand-name and generic pharmaceutical firms / patent law / chemical entity / federal food / drug products / /
Rutgers / Bureau of National Affairs / Food and Drug Administration / U.S. Patent and Trademark Office / U.S. government / Yale / University of Baltimore / World Trade Organization / Congress / U.S. Supreme Court / United States Patent and Trademark Office / U.S. Court of Appeals / Obama Administration / Congressional Research Service / /
Person
Elizabeth H. Dickinson / David Duffield Rohde / John D. Radice / Jerome H. Reichman / Maxwell R. Morgan / Anna B. Laakmann / Martin S. Masar III / Benjamin N. Roin / Sailesh K. Patel / Timothy A. Cook / Mark A. Lemley / Brian F. McMahon / D. Christopher Ohly / Linda P. Nussbaum / Brook K. Baker / Marquette Intellectual / Rebecca S. Eisenberg / John R. Thomas / Colleen Kelly / C. Scott Hemphill / Robert Alan Hess / Mustafa Ünlü / Yaniv Heled / /
. The Role of Patents and Regulatory Exclusivities in Pharmaceutical Innovation John R. Thomas Visiting Scholar